Horizon's Cell Lines to Aid Sanger, Mass General in Guiding Oncologics Administration with PGx
August 25, 2010
Horizon's Cell Lines to Aid Sanger, Mass General in Guiding Oncologics Administration with PGx
The UK-based firm will provide Sanger with more than 200 genetically defined cell lines with cancer-causing mutations, which will guide researchers working on the Genomics of Drug Sensitivity in Cancer project.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.